Accuray (ARAY) Cash from Investing Activities (2010 - 2026)

Accuray's (ARAY) quarterly Cash from Investing Activities came in at -$1.5 million in Q1 2026, up 70.59% year-on-year from -$882809.8 in Q1 2025, and up 73.09% quarter-over-quarter from -$5.6 million in Q4 2025.

Accuray (ARAY) Cash from Investing Activities (2010 - 2026) Analysis & Trends

Accuray's Cash from Investing Activities history runs 17 years deep, the most recent figure standing at -$1.5 million for Q1 2026.

  • On a quarterly basis, Cash from Investing Activities rose 70.59% year-over-year to -$1.5 million in Q1 2026; TTM through Mar 2026 was -$16.0 million, a 46.59% decrease from a year earlier, with the FY2025 full-year figure at -$8.5 million, down 136.68% from the prior year.
  • Cash from Investing Activities grew to -$1.5 million in Q1 2026 per ARAY's latest filing, from -$5.6 million in the prior quarter.
  • Across five years, Cash from Investing Activities topped out at -$1.1 million in Q3 2023 and bottomed at -$5.6 million in Q4 2025.
  • The 5-year median for Cash from Investing Activities is -$1.6 million (2024), against an average of -$2.7 million.
  • Across the five-year window, Cash from Investing Activities slumped 256.43% in 2025 and jumped 70.59% in 2026, its largest moves.
  • Year by year, Cash from Investing Activities stood at -$1.5 million in 2022, then climbed by 18.58% to -$1.2 million in 2023, then slipped by 25.7% to -$1.6 million in 2024, then slumped by 256.43% to -$5.6 million in 2025, then surged by 73.09% to -$1.5 million in 2026.
  • Per Business Quant, the three latest ARAY Cash from Investing Activities figures stand at -$1.5 million (Q1 2026), -$5.6 million (Q4 2025), and -$3.8 million (Q3 2025).

Peer Comparison

# Company Market Cap Enterprise Value Gross Profit (Qtr) Cash from Investing Activities (Qtr)
1 Abbott Laboratories 183.95 Bn 176.66 Bn 6.27 Bn -20.32 Bn
2 Stryker 128.83 Bn 125.95 Bn 3.81 Bn -185.00 Mn
3 Medtronic 108.81 Bn 99.59 Bn 6.41 Bn -917.00 Mn
4 Boston Scientific 68.39 Bn 66.94 Bn 3.61 Bn -591.00 Mn
5 Edwards Lifesciences 48.28 Bn 44.60 Bn 1.29 Bn -92.80 Mn
6 Dexcom 28.39 Bn 27.27 Bn 750.30 Mn -298.50 Mn
7 GE HealthCare Technologies 28.30 Bn 26.01 Bn 1.98 Bn -2.50 Bn
8 Smith & Nephew 26.95 Bn 26.37 Bn - -
9 Koninklijke Philips 25.45 Bn 22.32 Bn 2.07 Bn -475.32 Mn
10 Accuray 28,254.30 -38.51 Mn 25.29 Mn -1.51 Mn

Historic Data

Download Data
DateValue
Mar 31, 2026 -1.51 Mn
Mar 31, 2026 -1.51 Mn
Dec 31, 2025 -5.60 Mn
Dec 31, 2025 -5.60 Mn
Sep 30, 2025 -3.82 Mn
Sep 30, 2025 -3.82 Mn
Mar 31, 2025 -5.12 Mn
Mar 31, 2025 -5.12 Mn
Dec 31, 2024 -1.57 Mn
Dec 31, 2024 -1.57 Mn
Sep 30, 2024 -1.12 Mn
Sep 30, 2024 -1.12 Mn
Mar 31, 2024 -3.14 Mn
Mar 31, 2024 -3.14 Mn
Dec 31, 2023 -1.25 Mn
Dec 31, 2023 -1.25 Mn
Sep 30, 2023 -1.09 Mn
Sep 30, 2023 -1.09 Mn
Mar 31, 2023 -4.71 Mn
Mar 31, 2023 -4.71 Mn